Previous Article | Next Article ![]()
Infection and Immunity, June 2001, p. 3906-3915, Vol. 69, No. 6
Departments of
Pediatrics,1
Medicine,2 and
Pathology3 and Program of
Comparative Medicine,4 University of Maryland
School of Medicine, UMAB Cytokine Core
Laboratory,5 and Medicine and Research
Services of the Baltimore VA Medical
Center,6 Baltimore, Maryland
Received 12 September 2000/Returned for modification 13 November
2000/Accepted 5 March 2001
We previously observed that Ureaplasma urealyticum
respiratory tract colonization in infants with a birth weight of
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3906-3915.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Ureaplasma urealyticum Modulates
Endotoxin-Induced Cytokine Release by Human Monocytes Derived from
Preterm and Term Newborns and Adults
1,250 g was associated with increases in the tracheal aspirate
proinflammatory cytokines tumor necrosis factor alpha (TNF-
) and
interleukin-8 (IL-8) relative to the counterregulatory cytokine IL-6
during the first week of life (A. M. Patterson, V. Taciak, J. Lovchik, R. E. Fox, A. B. Campbell, and R. M. Viscardi,
Pediatr. Infect. Dis. J. 17:321-328, 1998). We hypothesized that
U. urealyticum alters the host immune response in the
presence of a coinflammatory stimulus (e.g., bacterial infection or
hyperoxia) by shifting the balance of cytokine expression towards the
proinflammatory cytokines. To test this hypothesis, we compared the
release of TNF-
, IL-8, IL-6, and IL-10 in vitro by unstimulated and
U. urealyticum (with or without lipopolysaccharide
[LPS])-stimulated human monocytes from adult peripheral blood and
from term and preterm cord blood. U. urealyticum alone
and in combination with LPS induced concentration- and
development-dependent changes in cytokine release. In vitro inoculation
with low-inoculum U. urealyticum (103
color-changing units [CCU]) (i) partially blocked the LPS-stimulated IL-6 release by all cells and reduced LPS-stimulated IL-10 release by
preterm cells, (ii) stimulated TNF-
and IL-8 release by preterm cells, and (iii) augmented LPS-stimulated TNF-
release in all cells.
In preterm cells, high-inoculum U. urealyticum
(106 CCU) (i) stimulated TNF-
and IL-8, but not IL-6 or
IL-10, release and (ii) augmented LPS-stimulated TNF-
and IL-8
release. High-inoculum U. urealyticum (i) stimulated
release of all four cytokines in term cells and IL-8 release in adult
cells and (ii) augmented LPS-induced TNF-
, IL-10, and IL-8 release
in term cells but did not significantly affect LPS-induced
cytokine release in adult cells. We speculate that U.
urealyticum enhances the proinflammatory response to a
second infection by blocking expression of counterregulatory cytokines
(IL-6 and IL-10), predisposing the preterm infant to prolonged and
dysregulated inflammation, lung injury, and impaired clearance of
secondary infections.
*
Corresponding author. Mailing address: Division of
Neonatology, Room N5W68, University of Maryland Hospital, 22 S. Greene St., Baltimore, MD 21201. Phone: (410) 706-1913. Fax: (410) 328-1076. E-mail: rviscard{at}umaryland.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»